CCR8⁺ regulatory T cell depletion overcomes immune checkpoint blockade resistance in BRCA2-deficient prostate cancer
BRCA2-mutated prostate cancer is an aggressive, genomically unstable subtype, yet how this genomic instability influences tumor immunity remains undefined.